ACTRN12614000051640.
Trial name or title | Preventing ‘chemo‐brain’: Can exercise mitigate chemotherapy‐induced cognitive impairment in breast cancer patients? |
Methods | RCT |
Participants | Breast cancer patients scheduled to receive adjuvant chemotherapy with fluorouracil‐epirubicin‐cyclophosphamide‐docetaxel (FEC‐T) or docetaxel‐cyclophosphamide (TC) regimens, target sample size: 66 |
Interventions | Combination of resistance (i.e. lifting weights) and aerobic exercise (e.g. walking, jogging, cycling), 2 times/week in an exercise clinic. moderate to high intensity (i.e. a perceived exertion of somewhat hard to hard) and will be relative to each participant's capabilities. Progressive exercise prescription, modified according to individual response. Approximately 60 min/session, small groups under the supervision of an accredited exercise physiologist. Length of program: will vary from 2.5 to 4 months according to the duration of the chemotherapy regimen Control group: usual care |
Outcomes | Primary outcome:
Secondary outcomes:
|
Starting date | June 2014 first participant enrolment |
Contact information | Dr Prue Cormie ECU Health and Wellness Institute Edith Cowan University 270 Joondalup Drive Joondalup, WA 6027, Australia |
Notes |